April 27 (Reuters) - Chinese life sciences entrepreneur Wei
Zhou submitted a $1.5 billion bid for U.S. gene testing company
Affymetrix last month - topping a $1.3 billion agreed
acquisition by Thermo Fisher Scientific Inc. A few days
later, he got an unusual deadline.
Read more
No comments:
Post a Comment